Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice

Journal of Virology

Volumn 76, Issue 5, 2002, Pages 2199-2205

  Tran, Robert K ^a   Lieu, Pauline T ^a   Aguilar, Santiago ^a   Wagner, Edward K ^a   Bloom, David C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA REPLICATION; FOOT PAD; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; KINETICS; LD 50; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPINAL GANGLION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; KINETICS; MICE; NEUROBLASTOMA; NEURONS; PROMOTER REGIONS (GENETICS); SPINAL CORD; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VIRULENCE; VIRUS REPLICATION;

EID: 0036168767     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.76.5.2199-2205.2002     Document Type: Article

References (20)

1. Comparative analysis of the parameters that regulate expression from promoters of two late HSV-1 gene products
2. HSV vectors for gene therapy
3. Neuronal specific restriction of an HSV recombinant maps to the UL5 gene
4. Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA
5. Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice
6. Transcriptional control of herpesvirus gene expression: Gene functions required for positive and negative regulation
7. Substitution of a TATA box from a herpes simplex virus late gene in the thymidine kinase promoter alters ICP4 inducibility but not temporal expression
8. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus
9. The exchange of cognate TATA boxes results in a corresponding promoter strength of two HSV-1 early promoters
10. The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells
11. A herpes simplex DNA polymerase mutation specifically attenuates neurovirulence in mice
12. Capsids are formed in a mutant virus blocked at the maturation site of the UL26 and UL26.5 open reading frames of herpes simplex virus type 1 but are not formed in a null mutant of UL38 (Vp19C)
13. A simple method of estimating fifty percent endpoints
14. The trans-activation of herpes simplex virus gene expression: Comparison of two factors and their cis sites
15. Establishment and characterization of multipotent neural stem cell lines using retrovirus vector-mediated oncogene transfer
16. Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product
17. Mutational analysis of two herpes simplex virus type 1 late promoters
18. Transcription of the herpes simplex virus genome during the productive and latent infections
19. Mutations within the N terminus of VP5 alter its interaction with the scaffold proteins of herpes simplex virus type 1
20. Transcriptional and posttranscriptional controls establish the cascade of herpes simplex virus protein synthesis